Marcus Bronzel

1.3k total citations · 2 hit papers
12 papers, 940 citations indexed

About

Marcus Bronzel is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Marcus Bronzel has authored 12 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Marcus Bronzel's work include Radiopharmaceutical Chemistry and Applications (7 papers), Medical Imaging Techniques and Applications (6 papers) and Prostate Cancer Treatment and Research (3 papers). Marcus Bronzel is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Medical Imaging Techniques and Applications (6 papers) and Prostate Cancer Treatment and Research (3 papers). Marcus Bronzel collaborates with scholars based in Germany, Austria and Denmark. Marcus Bronzel's co-authors include Clemens Kratochwil, Uwe Haberkorn, Frederik L. Giesel, Walter Mier, Hendrik Rathke, Klaus Kopka, Martina Benešová, Matthias Eder, M. Stefanova and Ali Afshar‐Oromieh and has published in prestigious journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging and Physica Medica.

In The Last Decade

Marcus Bronzel

12 papers receiving 932 citations

Hit Papers

PSMA-Targeted Radionuclide Therapy of Metastatic Castrati... 2016 2026 2019 2022 2016 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    2016 463 citations Clemens Kratochwil, Frederik L. Giesel et al. Journal of Nuclear Medicine profile →
  2. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding
    2017 378 citations Clemens Kratochwil, Frank Bruchertseifer et al. Journal of Nuclear Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus Bronzel Germany 6 828 683 288 84 69 12 940
Christoph A. Umbricht Switzerland 13 974 1.2× 702 1.0× 333 1.2× 119 1.4× 84 1.2× 15 1.1k
Florian Rosar Germany 21 823 1.0× 804 1.2× 290 1.0× 65 0.8× 64 0.9× 76 1.0k
Seval Beykan Germany 9 627 0.8× 507 0.7× 327 1.1× 54 0.6× 70 1.0× 13 843
Martina Weineisen Germany 7 742 0.9× 754 1.1× 250 0.9× 79 0.9× 78 1.1× 12 942
Fadi Khreish Germany 17 710 0.9× 686 1.0× 270 0.9× 59 0.7× 54 0.8× 46 867
Stefan Kürpig Germany 15 1.2k 1.4× 1.0k 1.5× 461 1.6× 97 1.2× 101 1.5× 25 1.3k
Ingo Klette Germany 12 1.1k 1.3× 842 1.2× 458 1.6× 92 1.1× 129 1.9× 21 1.3k
Mark Scalzo Australia 7 1.1k 1.3× 1.1k 1.6× 398 1.4× 110 1.3× 76 1.1× 10 1.3k
Astrid Gosewisch Germany 15 561 0.7× 405 0.6× 190 0.7× 47 0.6× 53 0.8× 24 732
Otto Knoesen South Africa 9 599 0.7× 489 0.7× 276 1.0× 58 0.7× 40 0.6× 20 695

Countries citing papers authored by Marcus Bronzel

Since Specialization
Citations

This map shows the geographic impact of Marcus Bronzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Bronzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Bronzel more than expected).

Fields of papers citing papers by Marcus Bronzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Bronzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Bronzel. The network helps show where Marcus Bronzel may publish in the future.

Co-authorship network of co-authors of Marcus Bronzel

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Bronzel. A scholar is included among the top collaborators of Marcus Bronzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Bronzel. Marcus Bronzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Prasad, Vikas, et al.. (2021). Effect of Peptide Dose on Radiation Dosimetry for Peptide Receptor Radionuclide Therapy with 177Lu-DOTATOC. Indian Journal of Nuclear Medicine. 36(4). 412–421. 1 indexed citations
2.
Jiménez‐Franco, Luis David, et al.. (2021). Automated and robust organ segmentation for 3D-based internal dose calculation. EJNMMI Research. 11(1). 53–53. 14 indexed citations
3.
Meyer, Philipp, Igor D. Grachev, Georg Becker, et al.. (2020). High sigma-1 receptor (S1R) but minimal dopamine-2 / dopamine-3 receptor (D2/D3R) occupancy at clinically relevant doses of pridopidine in healthy volunteers and Huntington disease patients investigated by using (S)-(-)-[18F]Fluspidine and [18F]Fallypride PET. 61. 338–338. 1 indexed citations
4.
Barthel, Henryk, Michael Rullmann, Georg‐Alexander Becker, et al.. (2020). Effect of Pridopidine in Huntington Disease (HD) Patients and Healthy Volunteers (HVs) – A Simultaneous Sigma-1 Receptor PET/Multimodality MRI Study. Nuklearmedizin - NuclearMedicine. 1 indexed citations
5.
Rathke, Hendrik, Paul Flechsig, Walter Mier, et al.. (2018). Dosimetry Estimate and Initial Clinical Experience with 90Y-PSMA-617. Journal of Nuclear Medicine. 60(6). 806–811. 35 indexed citations
6.
Lehnert, Wencke, et al.. (2018). [P086] Impact of modality (2D planar, 2D/3D hybrid, 3D SPECT) on kidneys absorbed dose in lu-177-based PRRT. Physica Medica. 52. 125–126. 2 indexed citations
7.
Lehnert, Wencke, et al.. (2018). Impact of Modality (2D Planar, 2D/3D Hybrid, 3D SPECT) on Kidneys Absorbed Dose in 177Lu-based PRRT. 59. 391–391. 4 indexed citations
8.
Kratochwil, Clemens, Frank Bruchertseifer, Hendrik Rathke, et al.. (2017). Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding. Journal of Nuclear Medicine. 58(10). 1624–1631. 378 indexed citations breakdown →
9.
Kratochwil, Clemens, Frederik L. Giesel, M. Stefanova, et al.. (2016). PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617. Journal of Nuclear Medicine. 57(8). 1170–1176. 463 indexed citations breakdown →
10.
Buchert, Ralph, Andreas Kluge, Livia Tossici-Bolt, et al.. (2016). Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. European Journal of Nuclear Medicine and Molecular Imaging. 43(7). 1323–1336. 30 indexed citations
11.
Lehnert, Wencke, et al.. (2016). Comparative Investigation of Internal Dosimetry Methodologies. 57. 307–307. 1 indexed citations
12.
Baum, Richard P., Andreas Kluge, Franz Josef Gildehaus, et al.. (2011). Systemic Endoradiotherapy with Carrier-Added 4-[131I]Iodo-L-Phenylalanine: Clinical Proof-of-Principle in Refractory Glioma. Nuclear Medicine and Molecular Imaging. 45(4). 299–307. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christoph A. Umbricht Breakdown of academic impact, for papers by Florian Rosar Breakdown of academic impact, for papers by Seval Beykan Breakdown of academic impact, for papers by Martina Weineisen Breakdown of academic impact, for papers by Fadi Khreish Breakdown of academic impact, for papers by Stefan Kürpig Breakdown of academic impact, for papers by Ingo Klette Breakdown of academic impact, for papers by Mark Scalzo Breakdown of academic impact, for papers by Astrid Gosewisch Breakdown of academic impact, for papers by Otto Knoesen
Rankless by CCL
2026